'CERBERUS' T CELLS: A SINGLE GLUCOCORTICOID-RESISTANT T CELL PRODUCT TO SIMULTANEOUSLY TARGET MULTIPLE PATHOGENS IN IMMUNOCOMPROMISED PATIENTS
EHA Library, Anastasia Papadopoulou, 295098
CD7 NANOBODY-DERIVED ANTI-CD7 CHIMERIC ANTIGEN RECEPTOR T-CELLS EXHIBITED POTENT ANTI-TUMOR ACTIVITIES TO CD7 POSITIVE MALIGNANCIES
EHA Library, Dan Chen, 295099
INITIAL SAFETY AND EFFICACY RESULTS WITH A SINGLE DOSE OF AUTOLOGOUS CRISPR-CAS9 MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IN TRANSFUSION-DEPENDENT Β-THALASSEMIA AND SICKLE CELL DISEASE
EHA Library, Selim Corbacioglu, 295100
FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF HEMATOPOIETIC STEM CELL-GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE I, HURLER (MPS-IH): PRELIMINARY EVIDENCE OF EXTENSIVE METABOLIC CORRECTION
EHA Library, Maria Ester Bernardo, 295101
OUTCOMES IN PATIENTS TREATED WITH LENTIGLOBIN FOR SICKLE CELL DISEASE (SCD) GENE THERAPY: UPDATED RESULTS FROM THE PHASE 1/2 HGB-206 GROUP C STUDY
EHA Library, Julie Kanter, 295102
AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-ALPHA2, RAPIDLY ENGRAFT AND MATURE IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY)
EHA Library, Fabio Ciceri, 295103
EARLY-PHASE CLINICAL TRIALS OF ADOPTIVE TRANSFER OF HYPERFUNCTIONAL NK CELLS EXPANDED EX VIVO WITH IL-21 DEMONSTRATE FUNCTIONAL, PHENOTYPIC, AND HAPLOTYPE-SPECIFIC EVIDENCE OF IN VIVO PERSISTENCE
EHA Library, Dean A Lee, 295104
DONOR-DERIVED SLEEPING BEAUTY CD19 CAR CYTOKINE INDUCED KILLER (CIK) CELLS EXPAND AND PERSIST IN CHILDREN AND ADULTS WITH B-ALL RELAPSED POST HSCT
EHA Library, Chiara F Magnani, 295105
INTERIM ANALYSIS OF ZUMA-5: A PHASE 2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA
EHA Library, Caron A. Jacobson, 295106
CART19-BE-01: A EUROPEAN ACADEMIC TRIAL ON THE ADMINISTRATION OF ARI-0001 CELLS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND OTHER CD19+ LYMPHOPROLIFERATIVE DISORDERS
EHA Library, Valentín Ortiz-Maldonado, 295107
FIRST-IN-HUMAN CLINICAL TRIAL OF THE AUTOLOGOUS CD7-CART CELLS FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
EHA Library, Mingzhi Zhang, 295108
IMR-687, A HIGHLY SELECTIVE PHOSPHODIESTERASE 9 INHIBITOR (PDE9I), INCREASES F-CELLS AND FETAL HEMOGLOBIN IN A PH-2A INTERIM ANALYSIS
EHA Library, Biree Andemariam, 295109
CAL-H, A NOVEL SELF-INACTIVATING LENTIVIRAL VECTOR ENCODING HUMAN Y-GLOBIN(G16D) AND SHRNA734 INHIBITS SICKLING IN RBC DERIVED FROM CD34+ STEM/PROGENITOR CELLS OF SICKLE CELL DISEASE PATIENTS
EHA Library, Waleed Ghanima, 295110
EDIT-301: AN AUTOLOGOUS CELL THERAPY TO PROMOTE FETAL HEMOGLOBIN EXPRESSION FOR THE POTENTIAL TREATMENT OF SICKLE CELL DISEASE
EHA Library, Jack Heath, 295111
THE ORAL FERROPORTIN INHIBITOR VIT-2763 IMPROVES ERYTHROPOIESIS WITHOUT INTERFERING WITH IRON CHELATION THERAPY IN A MODEL OF BETA-THALASSEMIA
EHA Library, Naja Nyffenegger, 295112
THE ORAL FERROPORTIN INHIBITOR VIT-2763 PREVENTS HEMOLYSIS AND VASO-OCCLUSION IN A SICKLE CELL DISEASE MODEL
EHA Library, Vania Manolova, 295113
ASSESSMENT OF RESPONSE TO LUSPATERCEPT BY Β-GLOBIN GENOTYPE IN ADULT PATIENTS WITH Β-THALASSEMIA IN THE BELIEVE TRIAL
EHA Library, Maria Domenica Cappellini, 295114
IMPROVEMENT IN ERYTHROPOIESIS IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSEMIA FOLLOWING TREATMENT WITH BETIBEGLOGENE AUTOTEMCEL (LENTIGLOBIN FOR B-THALASSEMIA) IN THE PHASE 3 HGB-207 STUDY
EHA Library, John B. Porter, 295115
PROOF OF CONCEPT FOR THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT THALASSEMIA: INTERIM RESULTS FROM AN ONGOING, PHASE 2, OPEN-LABEL, MULTICENTER STUDY
EHA Library, Kevin HM Kuo, 295116
A HEPCIDIN MIMETIC, PTG-300, DEMONSTRATES PHARMACODYNAMIC EFFECTS INDICATING REDUCED IRON AVAILABILITY IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA SUBJECTS
EHA Library, Ashutosh Lal, 295117
HEMATOPOIETIC STEM CELLS WITH ERYTHROID SIGNATURE IN BETA-THALASSEMIA
EHA Library, Maria Rosa Lidonnici, 295118
WHOLE EXOME SEQUENCING OF A PATIENT WITH ATYPICAL CONGENITAL PURE RED CELL APLASIA HAS ENABLED THE IDENTIFICATION OF A NOVEL KEY ACTOR OF ERYTHROPOIESIS
EHA Library, Elia Colin, 295119
UNEXPLAINED SPLENOMEGALIES: INTERIM DATA OF THE FRENCH PROSPECTIVE MULTI-CENTER SPLENOMEGALY STUDY (SMS)
EHA Library, Guillaume Denis, 295120
METABOLIC PHENOTYPING FOR RARE HEREDITARY ANEMIA - APPLICATION FOR PYRUVATE KINASE DEFICIENCY
EHA Library, Birgit van Dooijeweert, 295121
CHARACTERIZATION OF THE ROLE OF C15ORF41 IN THE PHYSIOLOGICAL AND PATHOLOGICAL ERYTHROPOIESIS
EHA Library, Roberta Marra, 295122
ROLE OF FERROPTOSIS IN X-LINKED SIDEROBLASTIC ANEMIA
EHA Library, Koya Ono, 295123
HYPOFERREMIA CAUSED BY TLR2-CONTROLLED FERROPORTIN DOWNREGULATION IS MEDIATED BY NFKB THROUGH HDAC-DEPENDENT AND -INDEPENDENT MECHANISMS
EHA Library, Oriana Marques, 295124
TRANSFERRIN RECEPTOR 2 TARGETING AMELIORATES ANEMIA OF CHRONIC KIDNEY DISEASE
EHA Library, Violante Olivari, 295125
COMBINATORIAL TARGETING OF THE TWO HEPCIDIN INHIBITORS FKBP12 AND TMPRSS6 TO UPREGULATE HEPCIDIN IN MICE.
EHA Library, Mariateresa Pettinato, 295126
SELECTIVE INHIBITION OF ALK2 SIGNALING AMELIORATES DISEASE IN A NOVEL MODEL OF IRON REFRACTORY IRON DEFICIENCY ANEMIA (IRIDA).
EHA Library, Thomas Backus, 295127
ELEVATED LIVER IRON INCREASES GLUCONEOGENESIS IN BETA-THALASSEMIA MICE
EHA Library, Heinrich Lob, 295128
SHORT VERSUS EXTENDED ANTIBIOTIC TREATMENT WITH A CARBAPENEM FOR HIGH-RISK FEBRILE NEUTROPENIA IN HEMATOLOGY PATIENTS WITH FEVER OF UNKNOWN ORIGIN: A RANDOMIZED MULTICENTER NON-INFERIORITY TRIAL.
EHA Library, Nick De Jonge, 295129
STOPPING ANTIBIOTIC THERAPY AFTER 72 HOURS IN PATIENTS WITH FEBRILE NEUTROPENIA UNDERGOING INTENSIVE CHEMOTHERAPY FOR AML/MDS (SAFE STUDY): A RETROSPECTIVE COMPARATIVE COHORT STUDY
EHA Library, Alexander Schauwvlieghe, 295130
A RANDOMISED TRIAL OF TWO 2-DOSE INFLUENZA VACCINATION STRATEGIES FOR PATIENTS FOLLOWING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Ben Teh, 295131
DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) IN HAEMATOLOGICAL PATIENTS - SINGLE CENTRE 14 YEARS EXPERIENCE
EHA Library, Martina Palackova, 295132
ANTI-CD 19 CHIMERIC ANTIGEN RECEPTORS T-CELLS (CAR T) FOR AGGRESSIVE NON HODGKIN LYMPHOMA (NHL) AND INFECTIOUS COMPLICATIONS. A MONOCENTRIC EXPERIENCE.
EHA Library, Roberta Di Blasi, 295133
ANKRD26: A NEW REGULATOR OF CYTOKINE-MEDIATED SIGNALING
EHA Library, Francesca Basso-Valentina, 295134
SAFETY AND EFFICACY OF RILZABRUTINIB (PRN1008), AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN RELAPSED/REFRACTORY PATIENTS WITH PRIMARY OR SECONDARY IMMUNE THROMBOCYTOPENIA: PHASE I/II ADAPTIVE STUDY
EHA Library, David Kuter, 295135
GLUCOCORTICOID RECEPTOR MODULATES MYELOID-DERIVED SUPPRESSOR CELLS FUNCTION VIA MITOCHONDRIAL METOBOLISM IN IMMUNE THROMBOCYTOPENIA
EHA Library, Shaoqiu Leng, 295136
SELECTIVE IMMUNOPROTEASOME INHIBITOR, KZR-616, A NOVEL THERAPY FOR AUTOIMMUNE HEMOLYTIC ANEMIA AND IMMUNE THROMBOCYTOPENIA: BIOMARKER ACTIVITY AND PHASE II CLINICAL TRIAL IN PROGRESS (MARINA)
EHA Library, Julia Lawrence, 295137
CLINICAL SPECTRUM, OUTCOME AND MANAGEMENT OF IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
EHA Library, Vincent Jachiet, 295138
AN INTERNATIONAL MULTICENTER STUDY OF SYSTEMIC BEVACIZUMAB FOR BLEEDING IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: THE INHIBIT-BLEED STUDY
EHA Library, Hanny Al-Samkari, 295139
NOVEL MANIFESTATIONS OF IMMUNE DYSREGULATION AND GRANULE DEFECTS IN GRAY PLATELET SYNDROME
EHA Library, Janine Collins, 295140
NEW INSIGHTS INTO HEMOPHILIA B LEYDEN
EHA Library, Saad Ahmed, 295141
CHARACTERIZATION OF THE PLATELET DISORDER CAUSED BY RUNX1 GERMLINE MUTATION IN A CRISPR/CAS9-GENERATED MURINE MODEL
EHA Library, Ana Marin Quilez, 295142
VTE-BLEED SCORE TO PREDICT BLEEDING COMPLICACTIONS IN PATIENS WITH VENOUS THROMBOEMBOLISM: FROM THE RIETE REGISTRY
EHA Library, Marta Hidalgo, 295143
UNDERLYING CANCER IN PATIENTS WITH ARTERIAL THROMBOEMBOLISM
EHA Library, Avi Leader, 295144
WHOLE EXOME ANALYSIS IDENTIFIED TWO NEW GENETIC VARIANTS CAUSING ANTITHROMBIN DEFICIENCY BY A SPECIFIC INEFFICIENT N-GLYCOSYLATION: IDENTIFICATION OF A NON-CANONICAL RESIDUE (LYS) AFFECTING N-SEQUONS.
EHA Library, Maria Eugenia Barrio, 295145
INCREASED RISK OF VENOUS AND ARTERIAL THROMBOSIS IN ALK-REARRANGED LUNG CANCER
EHA Library, Hanny Al-Samkari, 295146
A THROMBIN GENERATION-BASED RISK SCORE PREDICTS FOR EARLY DISEASE RECURRENCE IN HIGH-RISK BREAST CANCER PATIENTS: VALIDATION BY TWO DIFFERENT THROMBIN GENERATION ASSAYS
EHA Library, Patricia Gomez-Rosas, 295147
IMPACT OF COLD AGGLUTININ DISEASE REAL-WORLD TREATMENTS ON THROMBOSIS AND MORTALITY—A UNITED STATES ELECTRONIC HEATH RECORD DATABASE ANALYSIS
EHA Library, Jun Su, 295148
IMPLEMENTATION OF THE HM-PRO IN CLINICAL PRACTICE: HAEMATOLOGISTS' EXPERIENCE
EHA Library, Tatyana Ionova, 295149
THE ANEMIA-INDEPENDENT EFFECT OF MYELODYSPLASTIC SYNDROMES ON HEALTH-RELATED QUALITY OF LIFE
EHA Library, Hanneke Wouters, 295150
LONG-TERM PROTEASOME INHIBITION IN MULTIPLE MYELOMA (MM) FOLLOWING AN IN-CLASS TRANSITION FROM BORTEZOMIB (BTZ) TO IXAZOMIB (IXA): UPDATED REAL-WORLD (RW) DATA FROM THE US MM-6 COMMUNITY-BASED STUDY
EHA Library, Sudhir Manda, 295151
SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
EHA Library, Alexander Röth, 295152
HEALTH-RELATED QUALITY OF LIFE WITH CC-486 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST REMISSION FOLLOWING INDUCTION CHEMOTHERAPY (IC): RESULTS FROM THE PHASE III QUAZAR AML-001 TRIAL
EHA Library, Gail Roboz, 295153
HYPOXIA INDUCES A DORMANCY STATE THROUGH MTOR SIGNALING INHIBITION AND PROMOTES CHEMORESISTANCE IN T-ALL
EHA Library, Francoise Pflumio, 297690
COMPARISON OF TWO QPCR-BASED METHODS FOR MEASUREMENT OF MINIMAL RESIDUAL DISEASE IN B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THREE MAJOR FUSION TRANSCRIPTS
EHA Library, Ying-Jung Huang, 297691
CIRCULATING MICRORNAS AS MINIMAL RESIDUAL DISEASE BIOMARKERS IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Andrea Rzepiel, 297692
SERO-PROFILING OF ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IDENTIFIES NEW MEMBERS OF THE IMMUNOME.
EHA Library, Sarah Goodman, 297693
HIGH ECM1 TRANSCRIPT LEVELS AT DIAGNOSIS PREDICATED POOR PROGNOSIS IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Weimin Wang, 297694
TARGETING NUCLEOLIN FOR IMPROVING SUSCEPTIBILITY TO CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yanxin Chen, 297695
CYTOKINES TGFΒ1, TNF AND PHAGOCYTOSIS IN PERIPHERAL BLOOD (PB) OF ADULT PATIENTS (PTS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AS MARKERS OF SPREAD DISEASES
EHA Library, Vira Barilka, 297696
THERAPEUTIC POTENTIAL OF PIMOZIDE IN ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINES
EHA Library, Ana Bela Sarmento-Ribeiro, 297697
11Q23/MLL REARRANGEMENTS IN ADULT ACUTE LEUKEMIA
EHA Library, Olena Zotova, 297698
COPY NUMBER PROFILE AND OUTCOME ANALYSIS OF STIL-TAL1 POSITIVE PEDIATRIC T-ALL
EHA Library, Prateek Bhatia, 297699
IMPACT OF MINIMAL RESIDUAL DISEASE BY FLOW CYTOMETRY ON THERAPEUTIC RESULTS OF ACUTE LYMPHOBLASTIC LEUKEMIAS
EHA Library, Imen Frikha, 297700
STR-PROFILE STABILITY IN LEUKEMIA CELLS: IN-VITRO TESTING OF LYMPHOBLASTOID CELL LINES.
EHA Library, Natalya Risinskaya, 297701
GENETIC VARIANT OF TUMOR NECROSIS FACTOR-Α AND INTERLEUKIN-10 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Mohamed Elbaiomy, 297702
OUTCOME OF ASPARAGINASE ASSOCIATED PANCREATITIS IN EGYPTIAN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Sara Makkeyah, 297703
RISK FACTORS AND OUTCOMES OF CENTRAL NERVOUS SYSTEM RELAPSE IN HISPANIC ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Roberta Demichelis-Gomez, 297704
CHILDHOOD AND ADOLESCENTS-YOUNG ADULTS T ACUTE LYMPHOBLASTIC LEUKEMIA IN SOUTH OF TUNISIA
EHA Library, Imen Ben Amor, 297705
AUGMENTED BFM VERSUS GRAALL-2003 IN YOUNG ADULTS WITH PHILADELPHIA NEGATIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA; SINGLE CENTER EXPERIENCE.
EHA Library, Shaimaa El-Ashwah, 297706
A SIMPLE PROGNOSTIC SCORE PREDICTS MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (ALL/LL)
EHA Library, Ana Vagos Mata, 297707
HIGH-HYPERDIPLOIDY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: CYTOGENETIC,CLINICAL AND PROGNOSTIC IMPLICATIONS
EHA Library, MARIA KOURTI, 297708
ACUTE B-LYMPHOBLASTIC LEUKEMIA IN ADULTS WITH DOWN-SYNDROME: HIGH INFECTION COMPLICATION AND WORSE OUTCOME IN A VERY RARE AND DIFFICULT TO TREAT PATIENT COHORT
EHA Library, Philipp Hockl, 297709
RESULTS OF COOPRALL 2007 PROTOCOL IN THE TREATMENT OF FIRST RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Imen Ben Amor, 297710
CLINICAL CHARACTERISTICS AND SURVIVAL IMPACT OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS WITH 11Q23 REARRANGEMENT FROM A REFERENCE CENTER IN MEXICO.
EHA Library, Cynthia Pelayo, 297711
TREATMENT MODALITIES AND OUTCOMES OF ADULT PATIENTS WITH T-ALL TREATED IN A THIRD-LEVEL CENTER IN MEXICO.
EHA Library, Cynthia Pelayo, 297712
CLINICAL, CYTOGENETIC AND IMMUNOPHENOTYPIC FEATURES OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND POSITIVE TEL-AML 1 FUSION GENE
EHA Library, MARIA KOURTI, 297713
UNUSUAL LATE EXTRAMEDULLARY RELAPSE OF CHILDHOOD ACUTELYMPHOBLASTIC LEUKEMIA IN THE MAXILLARY SINUS
EHA Library, Marta Raimondo, 297714
NONHEMATOLOGIC TOXICITY OF IMATINIB MESYLATE IN PEDIATRIC PATIENT WITH PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
EHA Library, Rosanna Parasole, 297715
SEIZURE AS A RARE SIDE EFFECT OF L-ASPARAGINASE INFUSION IN A LEUKEMIC CHILD WITH DOWN SYNDROME
EHA Library, Alper Ozcan, 297716
DNA REPAIR GENES’ EXPRESSION ABNORMALITIES IN DE NOVO ACUTE MYELOGENOUS LEUKEMIA (AML): IMPLICATIONS FOR TARGETED TREATMENT
EHA Library, Vassiliki Pappa, 297717
CELL-CELL COMMUNICATION ANALYSIS IN MALIGNANT AND HEALTHY BONE MARROW USING COMUNET ALGORITHM ON SINGLE-CELL RNA-SEQ DATA
EHA Library, Maria Solovey, 297718
CAN NRF2 MODULATION BE A NOVEL THERAPEUTIC APPROACH IN ACUTE MYELOBLASTIC LEUKEMIA?
EHA Library, Ana Bela Sarmento-Ribeiro, 297719
IDH2 MUTATIONS COULD BE AN USEFUL MRD MARKER IN ACUTE MYELOID LEUKEMIA.
EHA Library, Sara Galimberti, 297720
HIGHLY EXPRESSED RIBOSOMAL PROTEIN L34 PREDICTS POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA AND COULD BE A POTENTIAL THERAPY TARGET
EHA Library, Liang Wang, 297721
EFFECTS OF E35-INDUCED AUTOPHAGY AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA HL-60 AND KASUMI CELLS
EHA Library, Li Zhang, 297722
TRANSCRIPTOME ANALYSIS OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE
EHA Library, Lilit Ghukasyan, 297723
HIGH LEVELS OF LEUKEMIC STEM CELLS CORRELATE WITH UNFAVORABLE PROGNOSIS IN A BRAZILIAN COHORT OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE.
EHA Library, Lorena Figueiredo-Pontes, 297724
EXPERIMENTAL APPROACH TO PERSONALIZED TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA BASED ON A CHEMOSENSITIVITY TEST
EHA Library, Hanna Trubkina, 297725
DEFICIENT REGULATORY INNATE LYMPHOID CELLS AND DIFFERENTIAL EXPRESSION OF MIRNAS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND APLASTIC ANEMIA
EHA Library, Jifeng Yu, 297726
AN IMMUNE RISK SCORE PREDICTS SURVIVAL OF PERSONS WITH ACUTE MYELOID LEUKEMIA RECEIVING CHEMOTHERAPY
EHA Library, Yang Liang, 297727
RARE TRANSLOCATION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Sarka Ransdorfova, 297728
ABNORMAL MITOCHONDRIAL DYNAMICS IN RELAPSE/REFRACTORY AML:IMBALANCE OF MITOCHONDRIAL FUSION AND DIVISION
EHA Library, Zhilong Xu, 297729
IDENTIFICATION OF NOVEL RELAPSE-ASSOCIATED GENETIC MARKERS OF ACUTE MYELOID LEUKEMIA BY WHOLE-EXOME SEQUENCING AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Mengge Gao, 297730
CYTOGENETICS' IMPACT ON THE PROGNOSIS OF PEDIATRIC ACUTE MYELOID LEUKEMIA AMONG DIFFERENT AGE GROUPS
EHA Library, Georgia Avgerinou, 297731
CLINICAL SIGNIFICANCE OF GATA1, GATA2 AND TAL1 EXPRESSION SIGNATURES IN ACUTE MYELOID LEUKEMIA.
EHA Library, Elmira Vagapova, 297732
ACUTE MYELOID LEUKEMIA WITH ETV6 GENE REARRANGEMENTS
EHA Library, Elena Zerkalenkova, 297733

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings